Celeste Krewson, Assistant Editor

In a recent study, women with an interpregnancy interval under 3 months, more often had worse pregnancy outcomes compared to those with an interval of 3 to under 6 months or of 6 to 12 months.

In a recent study, no significant differences were observed in menstrual cycle health and behaviors based on how an individual tracked their cycles.

In a recent study, physical abnormalities were seen among children born from pregnancies complicated by fentanyl.

In a recent story, a completed abortion was reported in 98.6% of patients taking a misoprostol alone regimen.

In a recent study, participants at different levels of socioeconomic disadvantage had varying associations between maternal cortisol production and fetal amygdala development.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, vaginal laxity symptoms were significantly improved in patients receiving electroporation therapy vs placebo.

Women of reproductive age often use combined hormonal contraceptives, which are available orally, as a vaginal ring, or as a transdermal patch. However, CHCs are associated with increased risks of venous thromboembolism and myocardial infarction (MI).

In a recent study, pregnant women in South Korea were not at an increased risk of early abortive outcomes from COVID-19 vaccination and had increased protection against COVID-19.

In a recent study, therapeutic touch and music independently improved sleep quality in perimenopausal and postmenopausal women.

In a recent study, venous thromboembolism risk among oral contraceptive users was accurately measured by genetic variants.

In a recent study, an association was found between reactive oxygen species and cervical intraepithelial neoplasia.

In a recent study, patients with a higher maternal comorbidity score were at an increased risk of cesarean delivery.

In a recent study, opioid prescriptions were decreased among patients receiving a noninvasive bioelectronic treatment after cesarean delivery.

The annual percentage changes of cervical cancer incidence and mortality in Appalachian Kentucky from 2009 to 2019 were 2.9% and 4.5% respectively.

A recent review evaluated the potential of in vivo and in vitro methods for treating vulvovaginal candidiasis.

In a recent study, visual biofeedback of the introitus during pushing was more well-received by patients than viewing of the maternal face.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, placenta accreta spectrum was accurately predicted through transvaginal ultrasound examination methods.

In a recent study, personal preference was the most common reason for people who gave birth not to use prenatal telehealth care.

In a recent study, an association was found between gastrointestional treatment type and perceived infertility risk.

The risk of depression after a traumatic brain injury was 48% greater in women than men when evaluated in a recent study discussed at the ANESTHESIOLOGY 2023 Annual Meeting.

At IDWeek 2023, a presentation sharing the latest news in RSV vaccines.

This lecture, presented by Holly J. Pederson, MD, at The Menopause Society 2023 Annual Meeting, looked at combined oral contraceptives in BRCA carriers and other high-risk patients, and hormone therapy in postmenopausal gene carriers as well as other high-risk women.

Data has supported 2 novel methods of reducing postpartum hemorrhage risk after cesarean delivery, as discussed at the ANESTHESIOLOGY 2023 annual meeting.

In a recent study, automatically measured blastocyst morphometrics found a correlation between blastocyst size and the odds of implantation.

In a recent study, the association between adverse pregnancy outcomes and cardiovascular risks was increased among overweight and obese individuals.

In a recent study, women with worse mental and gastrointestinal health had stronger menopausal symptoms.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, vulvovaginal atrophy treatments with lower estradiol concentrations were the most effective at preventing breast cancer recurrence.